App-Quantinova.ai

Granzyme B Deficiency Protects Against Angiotensin II-induced Cardiac Fibrosis via a Perforin-independent Mechanism

Fang Cheng - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Angiotensin II

Short Term Improvement in Subtle Cardiac Dysfunction in Severely Obese Patients After Bariatric Surgery is Not Associated with Changes in Nt-pro-bnp: A Speckle Tracking Study

Julie Martin - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congestive heart failure

N/A

Relationships Between Mediterranea- and Wester- Dietary Patterns and Biomarkers Associated with Increased Cardiovascular Risk in Patients with Stable Coronary Heart Disease in the Global STABILITY Trial

Ralph A Stewart - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

ILS-969

A Canadian Pilot Randomized Controlled Trial for a Decision Support Intervention in de novo Implantable Cardioverter Defibrillator Candidates - Main findings

Michael H McGillion - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acquired immunodeficiency syndrome

N/A

The Impacts of Burst Exercise Compared to Sustained Exercise on the Cardiometabolic Status and Exercise Behavior of Newly Diagnosed Type 2 Diabetic Patients

Paul Poirier - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

The Healthy Weights Initiative

Mark Lemstra - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Obesity

N/A

Associations Between the Amount and Intensity of Physical Activity and Major Cardiovascular Events in Patients with Stable Coronary Heart Disease: Results From the STABILITY Trial

Claes Held - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

N/A

Apolipoprotein B/Apolipoprotein A-I Ratio and Progression of Aortic Valve Stenosis - Results From the PROGRESSA Study

Romain Capoulade - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Aortic stenosis

N/A

Do Patients with Uncomplicated Non-ST Segment Acute Coronary Syndromes Require Admission to Critical Care Units?

Meng Lin - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Markers of Survival in Septuagenarians and Octogenarians with Heterozygous or Homozygous Familial Hypercholesterolemia

Diane Brisson - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Geometry, Reintervention, and Growth Patterns in the Reconstructed Aortic Arch with Interdigitating Technique in Patients with Hypoplastic Left Heart Syndrome and Variants

Devin Chetan - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypoplastic left heart syndrome

N/A

Regional Changes in Cellular and Molecular Pathology in Children with End-stage Dilated Cardiomyopathy: Correlation with Cardiac Performance

Mei Sun - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

N/A

Results of a Phase I / II Multicenter Investigation of Udenafil in Adolescents After Fontan Palliation

Victor Zak - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Udenafil

Influence of High Risk Adrenergic Receptor Genotypes on Outcome in Infants with Single Ventricle

Dorin Manase - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Efficacy and Safety of Dabigatran Compared with Warfarin in Patients with Atrial Fibrillation and Normal Renal Function Over Time: Insights From the RE-LY Trial

Stefan H Hohnloser - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

Pradax

The Association of Growth Patterns and Clinical Outcomes in Children with Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group

John L Jefferies - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congestive heart failure

N/A

Long Non-coding RNA Fingerprint Regulated by Stretch and Cyclic Strain in Vascular Smooth Muscle Cells: Implications for Aortic Aneurysms

Crystal Kantores - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Angiology

Hypertension

Bioflex

Neurologic Impact of Carotid Stenosis in Cardiac Surgery, a Retrospective Study

Olivier lesur - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Carotid artery stenosis

N/A

Computational Simulation of Virtual Ross Operation

Ismail El-Hamamsy - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic regurgitation

N/A

Therapeutic Inhibition of Mitochondrial Reactive Oxygen Species with Mito-tempo Reduces Diabetic Cardiomyopathy

Tianqing Peng - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic cardiomyopathy

Streptozotocin

Filters

28841 Abstracts